Teijin Limited completed the acquisition of 57.7% stake in Japan Tissue Engineering Co., Ltd. from Fujifilm Corporation for ¥19.2 billion
March 01, 2021
Share
Teijin Limited (TSE:3401) signed an agreement to acquire a 50.1% stake in Japan Tissue Engineering Co., Ltd. (JASDAQ:7774) from Fujifilm Corporation for ¥16.7 billion on January 29, 2021. Under the transaction, Fujifilm Corporation will tender all of its 20.36 million shares of Japan Tissue Engineering Co., Ltd. in a tender offer to be conducted by Teijin Limited at a price of ¥820 per share. If the tender offer is completed, the capital and business alliance between Fujifilm and Japan Tissue Engineering Co., Ltd. will be terminated and Japan Tissue Engineering Co., Ltd. will no longer be a consolidated subsidiary of Fujifilm. The tender offer will remain open from February 1, 2021 to March 2, 2021.
Teijin Limited (TSE:3401) completed the acquisition of 57.7% stake in Japan Tissue Engineering Co., Ltd. (JASDAQ:7774) from Fujifilm Corporation for ¥19.2 billion on March 2, 2021.
Japan Tissue Engineering Co Ltd is a Japan-based company mainly engaged in regenerative medicine product business, regenerative medicine outsourcing business, and research and development support business. The Company operates through three segments. The Regenerative Medicine Product segment develops regenerative medicine products using tissue engineering, and manufactures and sells the products for medical institutions. The regenerative medicine products include autologous cultured epidermis JACE, and autologous cultured cartilage JACK. The Regenerative Medicine Outsourcing segment provides contract development and manufacturing organization (CDMO) services, contract research organization (CRO) services, consulting services, and contract manufacturing services for specific cell processed products. The Research and Development Support segment manufactures and sells human cultured tissues that apply advanced culture technology accumulated through the development of in-house products.
JAPAN TISSUE ENGINEERING CO., LTD. 
